Mice expressing mutant Trpv4 recapitulate the human TRPV4 disorders

J Bone Miner Res. 2014 Aug;29(8):1815-1822. doi: 10.1002/jbmr.2220.

Abstract

Activating mutations in transient receptor potential vanilloid family member 4 (Trpv4) are known to cause a spectrum of skeletal dysplasias ranging from autosomal dominant brachyolmia to lethal metatropic dysplasia. To develop an animal model of these disorders, we created transgenic mice expressing either wild-type or mutant TRPV4. Mice transgenic for wild-type Trpv4 showed no morphological changes at embryonic day 16.5 but did have a delay in bone mineralization. Overexpression of a mutant TRPV4 caused a lethal skeletal dysplasia that phenocopied many abnormalities associated with metatropic dysplasia in humans, including dumbbell-shaped long bones, a small ribcage, abnormalities in the autopod, and abnormal ossification in the vertebrae. The difference in phenotype between embryos transgenic for wild-type or mutant Trpv4 demonstrates that an increased amount of wild-type protein can be tolerated and that an activating mutation of this protein is required to produce a skeletal dysplasia phenotype.

Keywords: CALCIUM CHANNEL; METATROPIC DYSPLASIA; SKELETAL DYSPLASIA; SMDK; TRANSGENIC MICE; TRPV4.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bone Development / genetics
  • Bone Diseases, Developmental / genetics*
  • Chondrocytes / metabolism
  • Gene Expression
  • Genetic Diseases, Inborn
  • Humans
  • Male
  • Mice
  • Mice, Transgenic
  • TRPV Cation Channels / genetics*
  • TRPV Cation Channels / metabolism*
  • Up-Regulation

Substances

  • TRPV Cation Channels